Lucid Diagnostics Inc expected to post a loss of 40 cents a share - Earnings Preview

Lucid Diagnostics

12/11/2022 01:06

* Lucid Diagnostics Inc  LUCD.OQ   LUCD.O  is expected
to show a
rise in quarterly revenue when it reports  results on November
14. 
    * The New York City-based  company is expected to report  a
112.5% increase in revenue to $425 thousand from $200 thousand a
year ago, according to the mean estimate from 4 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Lucid Diagnostics
Inc is
for a loss of 40 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Lucid
Diagnostics
Inc is $5​, above​ its last closing price of $2.23. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.36       -0.36      -0.41     Missed  -14.2
 Mar. 31 2022  -0.35       -0.33      -0.35     Missed  -5.3
 Dec. 31 2021  -0.20       -0.20      -0.32     Missed  -58​
 Sep. 30 2021  -0.32       -0.32      -0.49     Missed  -54.7
 ​​                                                     
                                                        ​
 This summary was machine generated November 12 at 01:06 GMT. 
All figures in US dollars  unless otherwise stated